Posted on Wednesday, March 16, 2011 at 8:19 am CDT
Particle size advancements in nasal spray suspensions using Raman chemical imaging will be presented by scientists at Gateway Analytical at the Pittcon Conference and Expo 2011.
Source: Gateway Analytical
Posted on Monday, March 14, 2011 at 11:41 am CDT
Barbara Wirostko, Chief Medical Officer of Altheos, will give featured presentation at GTC’s 3rd Ocular Diseases & Drug Discovery Conference, Boston, MA, May 26-27 2011
Source: GTCbio
Posted on Friday, March 11, 2011 at 7:30 pm CST
ResearchInChina, the vertical portal for Chinese business intelligence, announces the release of a new report - China Oral Hypoglyceimic Agents (OHAs) Industry Report, 2010
Source: researchInChina
Posted on Friday, March 04, 2011 at 8:15 pm CST
CCM will launch several customer rewards and incentives for clients who purchase the products in 2011
Source: CCM International Ltd
Posted on Friday, March 04, 2011 at 7:45 pm CST
CCM will launch several customer rewards and incentives for clients who purchase the products in 2011
Source: CCM International Ltd
Posted on Friday, March 04, 2011 at 11:46 am CST
Marcie Glicksman, Ph.D., Co-Director, Laboratory for Drug Discovery at Harvard Neurodiscovery Center to give presentation on “Protein Kinase Inhibitors for Neurodegenerative Diseases” at GTCbio’s 6th Protein Kinases in Drug Discovery Conference on May 26-27, 2011 in Boston, MA
Source: GTCbio
Posted on Monday, February 28, 2011 at 10:00 am CST
The report provides value (USD million) data for all the market categories – Dental Implants, Dental Chairs and Equipment, Dental Radiology Equipment, Dental Biomaterials, Crowns and Bridges and Dental Lasers
Source: MarketsandMarkets
Posted on Wednesday, February 16, 2011 at 9:30 pm CST
Advances in technology and rising patient awareness will drive the growth of the global insulin pumps market, says RNCOS in its latest research study.
Source: RNCOS
Posted on Wednesday, February 09, 2011 at 10:15 pm CST
Insulin pump market in the UAE has been estimated to account for the largest share of the insulin delivery devices market, says a new research report from RNCOS.
Source: RNCOS
Posted on Wednesday, February 09, 2011 at 7:45 pm CST
China is the birthplace of Chinese Patent Medicine, and a major producer and consumer of Chinese patent medicine in the world. Driven by both policy incentives and market demand, Chinese patent medicine has developed well in China. From 2006 to 2009, China’s industrial output value and sales revenue of Chinese patent medicine grew at annual rates of 13.9% and 12.7% respectively. The terminal sales revenue of Chinese patent medicine has always accounted for about 30% of the total pharmaceutical revenue of China since 2006. As of August 2010, there had been 1,522 Chinese patent medicine manufacturers in China, including over 30 listed companies, such as Tasly, Tongrentang and Yunnan Baiyao; there had been over 10,000 kinds of Chinese patent medicine, such as Tasly’s Compound Danshen Dripping Pill (Fu Fang Dan Shen Di Wan), Tongrentang’s Bolus of Six Drugs Including Rehmannia (Liu Wei Di Huang Wan) and Bolus of Black-bone Chicken (Wu Ji Bai Feng Wan); there had been over 40 dosage forms, such as traditional bolus, ointment, powder and pellet as well as modern capsule, tablet and spray.
Source: researchInChina
Posted on Monday, February 07, 2011 at 3:45 am CST
METTLER TOLEDO today announced the availability of the on demand version of a highly succesful webinar in collaboration with Dionex Corporation which describes a unique automated approach to linearity testing.
Source: Mettler-Toledo International Inc.
Posted on Sunday, February 06, 2011 at 10:20 pm CST
The pharmaceutical market in Saudi Arabia is anticipated to grow at a CAGR of around 10% during 2010 - 2012, says a new research report from RNCOS.
Source: RNCOS
Posted on Thursday, January 27, 2011 at 9:53 am CST
The quantitative use of in situ ATR-FTIR for real time supersaturation assessment has been extremely well defined within the literature.
Source: Mettler-Toledo International Inc.
Posted on Thursday, January 27, 2011 at 3:30 am CST
Nowadays, fatty acid esters are irreplaceable components in modern cosmetics and skin care products.
Source: Mettler-Toledo International Inc.
Posted on Tuesday, January 18, 2011 at 9:11 am CST
We are a week away from North America’s leading biopharmaceutical event, Biomanufacturing Summit 2011, taking place from January 24-25 in San Diego, California.
Source: World Trade Group
Posted on Monday, January 17, 2011 at 10:45 pm CST
With major blockbuster drugs getting expired in coming days, the US generics market is expected to grow at the CAGR of 10% during 2010-2013, says RNCOS.
Source: RNCOS
Posted on Saturday, January 15, 2011 at 4:15 am CST
METTLER TOLEDO announced the webinar - 20 Years of Reaction Calorimetry at Johnson and Johnson: Developing Improved and Safer Processes presented by Stephen M. Stefanick, of Johnson and Johnson, is now available on-demand.
Source: Mettler-Toledo International Inc.
Posted on Thursday, January 13, 2011 at 9:15 am CST
This report provides in depth coverage of the hepatitis market, incorporating a disease overview and detailed epidemiological analyses of the various hepatitis types.
Source: ReportsnReports
Posted on Friday, January 07, 2011 at 9:45 am CST
The Chinese hospital prescription pharma market generated sales of $22.9 billion in 2009, with an annual growth rate of 26.5% between 2008 and 2009. Key growth drivers include China’s support of foreign direct investment, low operating costs, growing economic wealth and a government stimulus of $125 billion to be spent on healthcare reforms during 2009–2011.
Source: ReportsnReports
Posted on Saturday, January 01, 2011 at 1:34 pm CST
This report analyzes the biopharmaceutical industry’s products, features, companies, market size and potential, and patent portfolios. The impact of the Medicare and Medicaid policies and individual plan behaviors on the biopharmaceutical industry is also discussed.
Source: ReportsnReports
Posted on Friday, December 31, 2010 at 11:58 am CST
Life Science Analytics’, Thrombosis Therapy Area Pipeline Report contains detailed information on the thrombosis drug pipeline. This report provides insight into the pipeline status of thrombosis drugs by company and by stage as well as a summary of the latest news and developments in this area.
Source: ReportsnReports
Posted on Tuesday, December 28, 2010 at 12:50 pm CST
GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – October 2010” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in September 2010. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.
Source: SandlerResearch
Posted on Tuesday, December 28, 2010 at 12:40 pm CST
The report portrays detailed comparative data on the number of deals and their value in the last five quarters, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.
Source: SandlerResearch
Posted on Friday, December 24, 2010 at 3:45 am CST
METTLER TOLEDO announced the webinar – The Importance of Mixing: How to Compare Lab Scale Mixing with Full Scale Process Vessel Performance – is now available on-demand. METTLER TOLEDO is proud to offer this free online seminar where presenter Ray Machado compares lab mixing and large scale mixing, while featuring two short courses he has given: Fundamentals of Scale-up and iControl Mixing Guidelines.
Source: Mettler-Toledo International Inc.
Posted on Tuesday, December 21, 2010 at 9:30 pm CST
Backed by the government support and patent expiries, Brazilian generics market is expected to grow at the CAGR of 19% during 2010-2012, RNCOS identified.
Source: RNCOS